Telemus Capital’s Revolution Medicines RVMD Stock Holding History

Telemus Capital’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,750	Closed	-$489K	–	429
2020 Q3	$489K	Buy	+10,750	New	+$298K	0.04%	303

Other funds holding RVMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Telemus Capital's RVMD Position: Q4 2020 in Review

Telemus Capital sold out of Revolution Medicines (RVMD) in Q4 2020, closing a stake of 10,750 shares — an estimated $489K sold.

Telemus Capital first reported a position in RVMD in Q3 2020 and held it in 1 quarter. The position peaked at $489K in Q3 2020. 119 funds tracked by Wall St. Rank hold RVMD as of Q4 2020.

Telemus Capital reported no remaining Revolution Medicines position as of Q4 2020 after selling out during the quarter.
Telemus Capital sold 10,750 Revolution Medicines shares in Q4 2020, an estimated $489K.
Telemus Capital first reported a position in Revolution Medicines in Q3 2020 and held it in 1 quarter.
Telemus Capital's Revolution Medicines position peaked at $489K in Q3 2020.
119 funds tracked by Wall St. Rank held Revolution Medicines as of Q4 2020.

Based on Telemus Capital's 13F filing for Q4 2020, filed 28 Jan 2021.